No redistribution of lung blood flow by inhaled nitric oxide in endotoxemic piglets pretreated with an endothelin receptor antagonist

Journal of Applied Physiology

Volumn 118, Issue 6, 2015, Pages 768-775

  Trachsel, Sebastien ^a,b   Hambraeus Jonzon, Kristina ^c   Bergquist, Maria ^a   Martijn, Cecile ^a   Chen, Luni ^a,d   Hedenstierna, Göran ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF BERN   (Switzerland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Endothelin receptor; Endothelin 1; Hypoxemia; Inhaled nitric oxide; Lung perfusion

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTOXIN; MESSENGER RNA; NITRIC OXIDE;

ANIMAL; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BREATHING; DRUG EFFECTS; HYPERTENSION, PULMONARY; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG CIRCULATION; LUNG INJURY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; VASOCONSTRICTION;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD PRESSURE; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDOTHELIN-1; ENDOTOXINS; HYPERTENSION, PULMONARY; LUNG; LUNG INJURY; NITRIC OXIDE; PULMONARY CIRCULATION; RECEPTORS, ENDOTHELIN; RESPIRATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RNA, MESSENGER; SWINE; VASOCONSTRICTION;

EID: 84925379611     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00591.2014     Document Type: Article

References (33)

1. Adhikari NK, Dellinger RP, Lundin S, Payen D, Vallet B, Gerlach H, Park KJ, Mehta S, Slutsky AS, Friedrich JO. Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med 42: 404-412, 2014.
2. Bourque SL, Davidge ST, Adams MA. The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. Am J Physiol Regul Integr Comp Physiol 300: R1288-R1295, 2011.
3. Bourque SL, Whittingham HA, Brien SE, Davidge ST, Adams MA. Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition. Br J Pharmacol 165: 1992-1999, 2012.
4. Checchia PA, Bronicki RA, Goldstein B. Review of inhaled nitric oxide in the pediatric cardiac surgery setting. Pediatric Cardiol 33: 493-505, 2012.
5. Chen L, He H, Fernandez Mondejar E, Freden F, Wiklund P, Alving K, Hedenstierna G. Endothelin-1 and nitric oxide synthase in short rebound reaction to short exposure to inhaled nitric oxide. Am J Physiol Heart Circ Physiol 281: H124-H131, 2001.
6. Della Rocca G, Coccia C. Nitric oxide in thoracic surgery. Minerva Anestesiol 71: 313-318, 2005.
7. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K Jr, Hyers TM, Papadakos P. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 26: 15-23, 1998.
8. Forni M, Mazzola S, Ribeiro LA, Pirrone F, Zannoni A, Bernardini C, Bacci ML, Albertini M. Expression of endothelin-1 system in a pig model of endotoxic shock. Regul Pept 131: 89-96, 2005.
9. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
10. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
11. Gattinoni L, D'Andrea L, Pelosi P, Vitale G, Pesenti A, Fumagalli R. Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA 269: 2122-2127, 1993.
12. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23: 499-502, 1993.
13. Hambraeus-Jonzon K, Chen L, Freden F, Wiklund P, Hedenstierna G. Pulmonary vasoconstriction during regional nitric oxide inhalation: evidence of a blood-borne regulator of nitric oxide synthase activity. Anesthesiology 95: 102-112, 2001.
14. Ichinose F. Improving outcomes after cardiac arrest using NO inhalation. Trends Cardiovasc Med 23: 52-58, 2013.
15. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84: 9265-9269, 1987.
16. Ivy DD, Kinsella JP, Abman SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. Journal Clin Invest 93: 2141-2148, 1994.
17. Kuklin VN, Kirov MY, Evgenov OV, Sovershaev MA, Sjoberg J, Kirova SS, Bjertnaes LJ. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep. Crit Care Med 32: 766-773, 2004.
18. Kumar P, Committee On F, Newborn. Use of inhaled nitric oxide in preterm infants. Pediatrics 133: 164-170, 2014.
19. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78: 1-5, 1986.
20. Nilsson MC, Hambraeus-Jonzon K, Lattuada M, Chen L, Li R, Alving K, Wiklund P, Hedenstierna G, Freden F. Distant effects of nitric oxide inhalation in endotoxemic pigs. Crit Care Med 38: 242-248, 2010.
21. Payen D, Bernard C, Beloucif S. Nitric oxide in sepsis. Clin Chest Med 17: 333-350, 1996.
22. Pearl JM, Nelson DP, Raake JL, Manning PB, Schwartz SM, Koons L, Shanley TP, Wong HR, Duffy JY. Inhaled nitric oxide increases endothelin-1 levels: a potential cause of rebound pulmonary hypertension. Crit Care Med 30: 89-93, 2002.
23. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338: 1173-1174, 1991.
24. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 14: R15, 2010.
25. Pipeling MR, Fan E. Therapies for refractory hypoxemia in acute respiratory distress syndrome. JAMA 304: 2521-2527, 2010.
26. Rapoport RM, Zuccarello M. Endothelin(A)-endothelin(B) receptor cross-talk and endothelin receptor binding. J Pharm Pharmacol 63: 1373-1377, 2011.
27. R Development Core Team. The R Project for Statistical Computing (Online). http://www.R-project.org/ [2014].
28. Rossi P, Wanecek M, Konrad D, Oldner A. Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange. Shock 21: 543-548, 2004.
29. Trachsel S, Deby-Dupont G, Maurenbrecher E, Nys M, Lamy M, Hedenstierna G. Association between inflammatory mediators and response to inhaled nitric oxide in a model of endotoxin-induced lung injury. Crit Care 12: R131, 2008.
30. Wanecek M, Oldner A, Sundin P, Alving K, Weitzberg E, Rudehill A. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock. Eur J Pharmacol 386: 235-245, 1999.
31. Weitzberg E, Hemsen A, Rudehill A, Modin A, Wanecek M, Lundberg JM. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol 118: 617-626, 1996.
32. West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures. J Appl Physiol 19: 713-724, 1964.
33. Zwissler B, Kemming G, Merkel M, Wolfram G, Kleen M, Habler O, Haller M, Briegel J. Response to inhaled nitric oxide (NO) is not associated with changes of plasma cGMP levels in patients with acute lung injury. Eur J Med Res 4: 463-467, 1999.